Man Group plc

Position in CCCC — C4 Therapeutics, Inc.

CIK 1637460 LONDON, X0

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,908,386

+$1,233,876 QoQ

Shares Held

408,648

+59.3% QoQ

Ownership

0.332%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 147 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

Man Group plc holds $1,094,353,895 across 113 Biotechnology names. CCCC ranks #61 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	436,956	$272,459,544
2	INCY	Incyte Corp	952,941	$108,025,391
3	ONC	BeOne Medicines Ltd.	307,463	$87,617,731
4	VRTX	Vertex Pharmaceuticals Inc / Ma	139,233	$69,161,207
5	APGE	Apogee Therapeutics, Inc.	397,000	$52,693,809
6	ALNY	Alnylam Pharmaceuticals, Inc.	170,907	$51,448,133
7	JAZZ	Jazz Pharmaceuticals plc	152,877	$36,838,770
8	RVMD	Revolution Medicines, Inc.	173,439	$32,481,655

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,908,386	408,648	+59.3%	Shares	Defined	2026-08-14
2026-03-31	$674,510	256,468	+64.3%	Shares	Defined	2026-05-15
2025-12-31	$298,147	156,098	+72.9%	Shares	Defined	2026-02-17
2025-09-30	$200,417	90,278	+15.0%	Shares	Defined	2025-11-14
2025-06-30	$112,236	78,487	-8.3%	Shares	Defined	2025-08-14
2025-03-31	$136,996	85,623	-38.8%	Shares	Defined	2025-05-15
2024-03-31	$1,142,982	139,900	-12.4%	Shares	Defined	2024-05-15
2023-12-31	$902,672	159,765	+130.4%	Shares	Defined	2024-02-14
2023-09-30	$281,228	151,198	+276.7%	Principal	Defined	2023-11-14
2023-06-30	$190,663	69,332	+979.4%	Shares	Defined	2023-08-14
2023-03-31	$126,023	40,135	—	Principal	Defined	2023-05-15
2021-09-30	$286,979	6,423	+18.4%	Shares	Defined	2021-11-15
2021-06-30	$205,206	5,423	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.